|
|
|
|
LEADER |
01638nam a2200361 u 4500 |
001 |
10029799 |
003 |
upatras |
005 |
20210117210012.0 |
008 |
990123m19981998ne eng |
020 |
|
|
|a 0792347927
|q (set)
|
020 |
|
|
|a 0792347900
|q (v.2)
|
020 |
|
|
|a 0792347919
|q (v.3)
|
040 |
|
|
|a GR-PaULI
|c GR-PaULI
|
041 |
0 |
|
|a eng
|
082 |
0 |
4 |
|a 615.19
|
245 |
1 |
0 |
|a 3D QSAR in drug design
|c edited by Hugo Kubinyi, Gerd Folkers, Yvonne C. Martin
|
260 |
|
|
|a Dordrecht
|b Kluwer Academic
|
300 |
|
|
|a 2 v.
|b fig.
|c 25 cm.
|
504 |
|
|
|a Includes bibliographical references and indexes
|
505 |
1 |
|
|a v.2. Ligand-protein interactions and molecular similarity. - vi, 416 p. - 1998 --
|a v.3. Recent advances. - vi, 352 p. - 1998.
|
650 |
|
4 |
|a Φάρμακα
|x Κατασκευή
|9 1265
|
650 |
|
4 |
|a Φαρμακολογία
|9 1400
|
650 |
|
4 |
|a Φαρμακοχημεία
|9 1032
|
700 |
1 |
|
|a Kubinyi, Hugo
|4 edt
|9 153321
|
700 |
1 |
|
|a Martin, Yvonne Connolly,
|d 1936-
|4 edt
|9 153322
|
700 |
1 |
|
|a Folkers, Gerd
|4 edt
|9 38222
|
852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|b ΒΣ1
|k ΑΣΧΞ
|h 615.19 K
|m 045584
|p 025000058922
|t 1
|3 v.2
|
852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|b ΒΣ1
|k ΑΣΧΞ
|h 615.19 K
|m 045781
|p 025000059197
|t 1
|3 v.3
|
942 |
|
|
|2 ddc
|c BK15
|
952 |
|
|
|0 0
|1 0
|3 v.2
|4 0
|6 615_190000000000000_K
|7 0
|9 198183
|a LISP
|b LISP
|c BSC
|d 2016-04-24
|i 045584
|l 0
|o 615.19 K
|p 025000058922
|r 2016-04-24 00:00:00
|t 1
|w 2016-04-24
|y BK15
|
952 |
|
|
|0 0
|1 0
|3 v.3
|4 0
|6 615_190000000000000_K
|7 0
|9 198184
|a LISP
|b LISP
|c BSC
|d 2016-04-24
|i 045781
|l 0
|o 615.19 K
|p 025000059197
|r 2016-04-24 00:00:00
|t 1
|w 2016-04-24
|y BK15
|
998 |
|
|
|c MANIAKH
|d 1999-09
|
999 |
|
|
|c 121701
|d 121701
|